Surgery Partners, Inc. Experiences Revision in Stock Evaluation Amid Market Volatility

Surgery Partners, Inc., a small-cap company in the hospital industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at $20.39, down from a previous close of $21.15, with a 52-week high of $33.37 and a low of $18.87. Today's trading saw a high of $21.19 and a low of $20.36, indicating some volatility in its performance.
The technical summary for Surgery Partners reveals a mixed outlook. The MACD indicators are bearish on both weekly and monthly scales, while the moving averages also reflect a bearish sentiment. However, the KST shows a mildly bullish trend on a weekly basis, contrasting with its monthly bearish stance. The Dow Theory presents a mildly bearish view weekly, while monthly indicators suggest a mildly bullish trend.

In terms of performance, Surgery Partners has faced challenges compared to the S&P 500. Over the past year, the stock has declined by 34.56%, while the S&P 500 has gained 17.82%. This trend continues over longer periods, with the stock underperforming the index significantly over three, five, and ten-year horizons. The recent evaluation adjustment highlights the need for close monitoring of Surgery Partners as it navigates these market conditions.